Medpace Holdings Inc vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Medpace Holdings Inc trades at $533.39 (market cap $15.08B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $53.22. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, First Trust NASDAQ Clean Edge Green Energy Idx Fd nearer its low. Which is the better fit depends on your goals.
| MEDP | QCLN | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $620.59 | $68.47 |
52-Week Low | $308.88 | $34.31 |
Enterprise Value | $14.55B | — |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
QCLN, a clean energy ETF, trades at $51.25, down 1.9% over 24 hours amid a bearish technical signal. The ETF faces headwinds from stalled U.S. renewable permits and supply chain pressures, though long-term demand for clean energy remains strong due to data center growth and global energy security concerns. Technical indicators show oversold conditions with RSI at 29.51, while moving averages signal a downtrend.
The outlook is cautious near-term due to policy uncertainty and cost inflation, but structural growth in low-emission power supports potential recovery. Risks include regulatory delays and Chinese trade tensions, while analyst sentiment is mixed with clean energy ETFs gaining attention for long-term energy transition themes.
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →